HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Evaluation of current algorithms for segmentation of scar tissue from late gadolinium enhancement cardiovascular magnetic resonance of the left atrium: an open-access grand challenge.

AbstractBACKGROUND:
Late Gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) imaging can be used to visualise regions of fibrosis and scarring in the left atrium (LA) myocardium. This can be important for treatment stratification of patients with atrial fibrillation (AF) and for assessment of treatment after radio frequency catheter ablation (RFCA). In this paper we present a standardised evaluation benchmarking framework for algorithms segmenting fibrosis and scar from LGE CMR images. The algorithms reported are the response to an open challenge that was put to the medical imaging community through an ISBI (IEEE International Symposium on Biomedical Imaging) workshop.
METHODS:
The image database consisted of 60 multicenter, multivendor LGE CMR image datasets from patients with AF, with 30 images taken before and 30 after RFCA for the treatment of AF. A reference standard for scar and fibrosis was established by merging manual segmentations from three observers. Furthermore, scar was also quantified using 2, 3 and 4 standard deviations (SD) and full-width-at-half-maximum (FWHM) methods. Seven institutions responded to the challenge: Imperial College (IC), Mevis Fraunhofer (MV), Sunnybrook Health Sciences (SY), Harvard/Boston University (HB), Yale School of Medicine (YL), King's College London (KCL) and Utah CARMA (UTA, UTB). There were 8 different algorithms evaluated in this study.
RESULTS:
Some algorithms were able to perform significantly better than SD and FWHM methods in both pre- and post-ablation imaging. Segmentation in pre-ablation images was challenging and good correlation with the reference standard was found in post-ablation images. Overlap scores (out of 100) with the reference standard were as follows: Pre: IC = 37, MV = 22, SY = 17, YL = 48, KCL = 30, UTA = 42, UTB = 45; Post: IC = 76, MV = 85, SY = 73, HB = 76, YL = 84, KCL = 78, UTA = 78, UTB = 72.
CONCLUSIONS:
The study concludes that currently no algorithm is deemed clearly better than others. There is scope for further algorithmic developments in LA fibrosis and scar quantification from LGE CMR images. Benchmarking of future scar segmentation algorithms is thus important. The proposed benchmarking framework is made available as open-source and new participants can evaluate their algorithms via a web-based interface.
AuthorsRashed Karim, R James Housden, Mayuragoban Balasubramaniam, Zhong Chen, Daniel Perry, Ayesha Uddin, Yosra Al-Beyatti, Ebrahim Palkhi, Prince Acheampong, Samantha Obom, Anja Hennemuth, Yingli Lu, Wenjia Bai, Wenzhe Shi, Yi Gao, Heinz-Otto Peitgen, Perry Radau, Reza Razavi, Allen Tannenbaum, Daniel Rueckert, Josh Cates, Tobias Schaeffter, Dana Peters, Rob MacLeod, Kawal Rhode
JournalJournal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance (J Cardiovasc Magn Reson) Vol. 15 Pg. 105 (Dec 20 2013) ISSN: 1532-429X [Electronic] England
PMID24359544 (Publication Type: Comparative Study, Evaluation Study, Journal Article, Multicenter Study, Research Support, Non-U.S. Gov't)
Chemical References
  • Contrast Media
Topics
  • Algorithms
  • Atrial Fibrillation (diagnosis, pathology)
  • Benchmarking
  • Cicatrix (diagnosis, pathology)
  • Contrast Media
  • Databases, Factual
  • Europe
  • Fibrosis
  • Heart Atria (pathology)
  • Humans
  • Image Interpretation, Computer-Assisted (standards)
  • Magnetic Resonance Imaging (standards)
  • Observer Variation
  • Predictive Value of Tests
  • Reproducibility of Results
  • United States

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: